Potential elucidation of a novel CTL epitope in HIV-1 protease by the protease inhibitor resistance mutation L90M.
The combination of host immune responses and use of antiretrovirals facilitate partial control of human immunodeficiency virus type 1 (HIV-1) infection and result in delayed progression to Acquired Immunodeficiency Syndrome (AIDS). Both treatment and host immunity impose selection pressures on the h...
Main Author: | Werner Smidt |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3756051?pdf=render |
Similar Items
-
Alteration of HIV epitope processing and presentation by HIV protease inhibitors
by: Kourjian G, et al.
Published: (2012-09-01) -
Deep sequencing of protease inhibitor resistant HIV patient isolates reveals patterns of correlated mutations in Gag and protease.
by: William F Flynn, et al.
Published: (2015-04-01) -
Sensing HIV Protease and Its Inhibitor Using “Helical Epitope”—Imprinted Polymers
by: Chien-Yu Chou, et al.
Published: (2020-06-01) -
Role of Gag in HIV Resistance to Protease Inhibitors
by: Fabrizio Mammano, et al.
Published: (2010-07-01) -
HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
by: Konvalinka Jan, et al.
Published: (2011-08-01)